{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:48:09Z","timestamp":1780404489145,"version":"3.54.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"DOI":"10.1097\/qai.0b013e3182961cfc","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T15:24:12Z","timestamp":1366125852000},"page":"485-493","source":"Crossref","is-referenced-by-count":36,"title":["Plasma and Mucosal HIV Viral Loads Are Associated With Genital Tract Inflammation in HIV-Infected Women"],"prefix":"10.1097","volume":"63","author":[{"given":"Betsy C.","family":"Herold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla J.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvi M.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy J.","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Minkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Colie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek J.","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gypsyamber","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Heather","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Anastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210131","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/590503","article-title":". Relationship between levels of inflammatory cytokines in the genital tract and CD4 cell counts in women with acute HIV-1 infection.","volume":"198","author":"Bebell","year":"2008","journal-title":"J Infect Dis"},{"key":"R2-11-20210131","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/infdis\/jir715","article-title":". Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women.","volume":"205","author":"Roberts","year":"2012","journal-title":"J Infect Dis"},{"key":"R3-11-20210131","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/QAD.0b013e3283367836","article-title":". Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.","volume":"24","author":"Roberts","year":"2010","journal-title":"AIDS"},{"key":"R4-11-20210131","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9440(10)62264-X","article-title":". Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression.","volume":"166","author":"Wang","year":"2005","journal-title":"Am J Pathol"},{"key":"R5-11-20210131","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1073\/pnas.0901983106","article-title":". Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa.","volume":"106","author":"Redd","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-11-20210131","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/527387","article-title":". Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.","volume":"46","author":"Kwara","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R7-11-20210131","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(01)06653-3","article-title":". Determinants of HIV-1 shedding in the genital tract of women.","volume":"358","author":"Kovacs","year":"2001","journal-title":"Lancet"},{"key":"R8-11-20210131","doi-asserted-by":"crossref","first-page":"12972","DOI":"10.1073\/pnas.2134064100","article-title":". HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation.","volume":"100","author":"Kemal","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-11-20210131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/aid.2010.0129","article-title":". Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.","volume":"27","author":"Mitchell","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R10-11-20210131","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1128\/JVI.00421-07","article-title":". MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands.","volume":"81","author":"Meier","year":"2007","journal-title":"J Virol"},{"key":"R11-11-20210131","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0897.2009.00768.x","article-title":". Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception.","volume":"63","author":"Shust","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"R12-11-20210131","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1086\/497168","article-title":". Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection.","volume":"192","author":"John","year":"2005","journal-title":"J Infect Dis"},{"key":"R13-11-20210131","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.4049\/jimmunol.175.11.7560","article-title":". Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.","volume":"175","author":"Venkataraman","year":"2005","journal-title":"J Immunol"},{"key":"R14-11-20210131","doi-asserted-by":"crossref","first-page":"e11366","DOI":"10.1371\/journal.pone.0011366","article-title":". Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.","volume":"5","author":"Ghosh","year":"2010","journal-title":"PLoS One"},{"key":"R15-11-20210131","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/QAD.0b013e328013d9b5","article-title":". PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.","volume":"21","author":"Keller","year":"2007","journal-title":"AIDS"},{"key":"R16-11-20210131","doi-asserted-by":"crossref","first-page":"e16475","DOI":"10.1371\/journal.pone.0016475","article-title":". A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1 tenofovir gel.","volume":"6","author":"Keller","year":"2011","journal-title":"PLoS One"},{"key":"R17-11-20210131","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1128\/IAI.00524-06","article-title":"Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis.","volume":"74","author":"Valore","year":"2006","journal-title":"Infect Immun"},{"key":"R18-11-20210131","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI118056","article-title":". Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.","volume":"96","author":"McNeely","year":"1995","journal-title":"J Clin Invest"},{"key":"R19-11-20210131","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/QAI.0b013e31826867ae","article-title":". Changes in the soluble mucosal immune environment during genital herpes outbreaks.","volume":"61","author":"Keller","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-11-20210131","doi-asserted-by":"crossref","first-page":"e40415","DOI":"10.1371\/journal.pone.0040415","article-title":". Altered biomarkers of mucosal immunity and reduced vaginal Lactobacillus concentrations in sexually active female adolescents.","volume":"7","author":"Madan","year":"2012","journal-title":"PLoS One"},{"key":"R22-11-20210131","doi-asserted-by":"crossref","first-page":"e49506","DOI":"10.1371\/journal.pone.0049506","article-title":". Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions.","volume":"7","author":"Kalyousef","year":"2012","journal-title":"PLoS One"},{"key":"R23-11-20210131","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","article-title":". Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.","volume":"22","author":"Atashili","year":"2008","journal-title":"AIDS"},{"key":"R24-11-20210131","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1086\/462427","article-title":". Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study.","volume":"192","author":"Myer","year":"2005","journal-title":"J Infect Dis"},{"key":"R25-11-20210131","doi-asserted-by":"crossref","first-page":"e1001251","DOI":"10.1371\/journal.pmed.1001251","article-title":". Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.","volume":"9","author":"Cohen","year":"2012","journal-title":"PLoS Med"},{"key":"R26-11-20210131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":". The Womens Interagency HIV Study. WIHS Collaborative Study Group.","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"R27-11-20210131","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.","volume":"29","author":"Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"R28-11-20210131","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1084\/jem.20041115","article-title":". Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection.","volume":"200","author":"Ma","year":"2004","journal-title":"J Exp Med"},{"key":"R29-11-20210131","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI21948","article-title":". Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.","volume":"115","author":"Chang","year":"2005","journal-title":"J Clin Invest"},{"key":"R30-11-20210131","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2006-05-024489","article-title":". Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4.","volume":"109","author":"Furci","year":"2007","journal-title":"Blood"},{"key":"R31-11-20210131","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/00002030-200405210-00020","article-title":". Alpha-defensins inhibit HIV infection of macrophages through upregulation of CC-chemokines.","volume":"18","author":"Guo","year":"2004","journal-title":"AIDS"},{"key":"R32-11-20210131","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1097\/00002030-200309260-00001","article-title":". alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors.","volume":"17","author":"Mackewicz","year":"2003","journal-title":"AIDS"},{"key":"R33-11-20210131","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1076185","article-title":". Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.","volume":"298","author":"Zhang","year":"2002","journal-title":"Science"},{"key":"R34-11-20210131","first-page":"138","article-title":". Alpha-defensins in the prevention of HIV transmission among breastfed infants.","volume":"39","author":"Kuhn","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-11-20210131","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/343805","article-title":". Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk.","volume":"186","author":"Farquhar","year":"2002","journal-title":"J Infect Dis"},{"key":"R36-11-20210131","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1086\/318535","article-title":". Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission.","volume":"183","author":"Pillay","year":"2001","journal-title":"J Infect Dis"},{"key":"R37-11-20210131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/QAD.0b013e328321809c","article-title":". Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition.","volume":"23","author":"Levinson","year":"2009","journal-title":"AIDS"},{"key":"R38-11-20210131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.qco.0000200291.37909.3b","article-title":"Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.","volume":"19","author":"Madan","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"R39-11-20210131","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":". Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8 T cells.","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"key":"R40-11-20210131","doi-asserted-by":"crossref","first-page":"e1000852","DOI":"10.1371\/journal.ppat.1000852","article-title":". Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation.","volume":"6","author":"Nazli","year":"2010","journal-title":"PLoS Pathog"},{"key":"R41-11-20210131","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/aid.2007.0268","article-title":". Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines.","volume":"24","author":"Mitchell","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R42-11-20210131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/jir260","article-title":". Endometrial epithelial cell responses to coinfecting viral and bacterial pathogens in the genital tract can activate the HIV-1 LTR in an NFkappaB-and AP-1-dependent manner.","volume":"204","author":"Ferreira","year":"2011","journal-title":"J Infect Dis"},{"key":"R43-11-20210131","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/OLQ.0b013e318255aeef","article-title":". Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation.","volume":"39","author":"Mhatre","year":"2012","journal-title":"Sex Transm Dis"},{"key":"R44-11-20210131","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1089\/aid.2011.0394","article-title":". Genital tract viral load in HIV type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of Infectious virus or anti-HIV activity.","volume":"28","author":"Mukura","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"suppl 3","key":"R45-11-20210131","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1093\/infdis\/jis200","article-title":"Immunologic basis of cardiovascular disease in HIV-infected adults.","volume":"205","author":"Hsue","year":"2012","journal-title":"J Infect Dis"},{"key":"R46-11-20210131","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/COH.0b013e32833ed6f4","article-title":"Biomarkers of immune dysfunction in HIV.","volume":"5","author":"Nixon","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"R47-11-20210131","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/QAD.0b013e3283489d1f","article-title":". The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.","volume":"25","author":"Keating","year":"2011","journal-title":"AIDS"},{"key":"R48-11-20210131","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/QAD.0b013e3283389dfa","article-title":". Inflammatory biomarkers and abacavir use in the Womens Interagency HIV Study and the Multicenter AIDS Cohort Study.","volume":"24","author":"Palella","year":"2010","journal-title":"AIDS"},{"key":"R49-11-20210131","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/13550280701620747","article-title":". Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women.","volume":"13","author":"Wojna","year":"2007","journal-title":"J Neurovirol"},{"key":"R50-11-20210131","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/09540121.2010.542128","article-title":". Recent cigarette smoking and HIV disease progression: no evidence of an association.","volume":"23","author":"Kabali","year":"2011","journal-title":"AIDS Care"},{"key":"R51-11-20210131","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/14622200801908190","article-title":"Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy.","volume":"10","author":"Shuter","year":"2008","journal-title":"Nicotine Tob Res"},{"key":"R52-11-20210131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/426394","article-title":". Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.","volume":"191","author":"Sha","year":"2005","journal-title":"J Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e3182961cfc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:01:29Z","timestamp":1620972089000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201308010-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3182961cfc","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,1]]}}}